scholarly journals Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution

2009 ◽  
pp. 199 ◽  
Author(s):  
Hyung Cho ◽  
Eric Wolf ◽  
Kenneth Wolf
2009 ◽  
Vol 87 (3) ◽  
pp. 300-305 ◽  
Author(s):  
Masaru Miyanaga ◽  
Takashi Miyai ◽  
Ryohei Nejima ◽  
Yoko Maruyama ◽  
Kazunori Miyata ◽  
...  

1999 ◽  
Vol 127 (3) ◽  
pp. 253-259 ◽  
Author(s):  
Jeff Heier ◽  
Janet K Cheetham ◽  
Ronald DeGryse ◽  
Monte S Dirks ◽  
Delmar R Caldwell ◽  
...  

2011 ◽  
Vol 27 (9) ◽  
pp. 1693-1703 ◽  
Author(s):  
Steven M. Silverstein ◽  
Melissa G. Cable ◽  
Ehsan Sadri ◽  
James H. Peace ◽  
Raymond Fong ◽  
...  

2021 ◽  
Vol Volume 15 ◽  
pp. 2847-2854
Author(s):  
Aldo Caporossi ◽  
Giovanni Alessio ◽  
Francesco Fasce ◽  
Giorgio Marchini ◽  
Antonio Rapisarda ◽  
...  

2020 ◽  
Vol 37 (4) ◽  
pp. 1664-1674 ◽  
Author(s):  
Paolo Fogagnolo ◽  
Eleonora Favuzza ◽  
Daniele Marchina ◽  
Michela Cennamo ◽  
Roberto Vignapiano ◽  
...  

2005 ◽  
Vol 15 (5) ◽  
pp. 598-606 ◽  
Author(s):  
P. Russo ◽  
V. Papa ◽  
S. Russo ◽  
A. Dl Bella ◽  
G. Pabst ◽  
...  

Purpose To investigate whether topical nonsteroidal anti inflammatory drugs (NSAIDs) are useful, in the absence of concomitant corticosteroid therapy, in limiting postoperative inflammation after uncomplicated cataract surgery. Methods A total of 328 patients were enrolled in a prospective, randomized, double-masked, parallel-group, active-controlled study. Anterior chamber inflammation (ACI) was evaluated as the primary efficacy parameter. Only patients with moderate inflammation (ACI score of ≤4) the day after surgery were randomized and treated with NSAIDs. A novel topical formulation containing 0.2% sodium naproxen was compared with 0.1% diclofenac. Both were administered three times a day for 14 consecutive days. Ocular inflammation was measured after 7 and 14 days by using slit-lamp biomicroscopy. Safety parameters were also evaluated at the same time. Results Both treatments were equally effective in controlling postsurgical inflammation. No statistically significant differences between treatment groups were observed for the safety variables. No serious adverse events (AEs) occurred during the course of the study. The most frequent AE reported with naproxen was eye redness. Conclusions NSAIDs can effectively be used without concurrent administration of corticosteroids to control postoperative inflammation after uncomplicated cataract surgery. In addition, naproxen ophthalmic solution may be considered a suitable alternative to the currently available NSAIDs.


Sign in / Sign up

Export Citation Format

Share Document